Scorpion Therapeutics is a clinical-stage oncology company committed to advancing precision medicine through the development of targeted therapies for cancer. Utilizing a proprietary and fully integrated platform that encompasses cutting-edge technologies in cancer biology, medicinal chemistry, and data science, Scorpion Therapeutics aims to create highly selective small molecule compounds across a diverse array of therapeutic targets. The company's mission centers on delivering transformative treatments to a broader patient population by developing a robust pipeline of wholly owned compounds, including best-in-class molecules for validated oncogene targets, first-in-class therapies for previously undruggable targets, and innovative candidates addressing novel cancer targets. Scorpion Therapeutics fosters a collaborative and inclusive environment, valuing teamwork and dedication to bringing critical medicines to patients in need.